GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » Free Cash Flow per Share

SANUWAVE Health (SANUWAVE Health) Free Cash Flow per Share

: $-0.01 (TTM As of Dec. 2023)
View and export this data going back to 2008. Start your Free Trial

SANUWAVE Health's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 43.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 20.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 20.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the FCF Growth Rate using Free Cash Flow per Share data.

The historical rank and industry rank for SANUWAVE Health's Free Cash Flow per Share or its related term are showing as below:

SNWV' s 3-Year FCF Growth Rate Range Over the Past 10 Years
Min: -668.6   Med: 25.6   Max: 57.1
Current: 43.9

During the past 13 years, SANUWAVE Health's highest 3-Year average Free Cash Flow per Share Growth Rate was 57.10% per year. The lowest was -668.60% per year. And the median was 25.60% per year.

SNWV's 3-Year FCF Growth Rate is ranked better than
89.07% of 622 companies
in the Medical Devices & Instruments industry
Industry Median: 0.5 vs SNWV: 43.90

SANUWAVE Health Free Cash Flow per Share Historical Data

The historical data trend for SANUWAVE Health's Free Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SANUWAVE Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Free Cash Flow per Share
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.03 -0.01 -0.03 -0.01

SANUWAVE Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Free Cash Flow per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - - - -

Competitive Comparison

For the Medical Devices subindustry, SANUWAVE Health's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SANUWAVE Health Price-to-Free-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Price-to-Free-Cash-Flow falls into.



SANUWAVE Health Free Cash Flow per Share Calculation

Free Cashflow per Share is the amount of Free Cashflow per outstanding share of the company's stock.

Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company.

Note: GuruFocus does not calculate Free Cash Flow Per Share when Capital Expenditure is 0.

SANUWAVE Health's Free Cash Flow Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Free Cash Flow Per Share(A: Dec. 2023 )
=(Cash Flow from Operations+Capital Expenditure)/Shares Outstanding (Diluted Average)
=(-4.538+0)/793.851
=/793.851
=0.00

SANUWAVE Health's Free Cash Flow Per Share for the quarter that ended in Dec. 2023 is calculated as

Free Cash Flow Per Share(Q: Dec. 2023 )
=(Cash Flow from Operations+Capital Expenditure)/Shares Outstanding (Diluted Average)
=(-1.285+0)/1124.090
=/1124.090
=0.00

Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SANUWAVE Health  (OTCPK:SNWV) Free Cash Flow per Share Explanation

Free Cash Flow is very close to Warren Buffett's definition of Owner's Earnings, except that in Warren Buffett's Owner's Earnings, the spending for Property, Plant, and Equipment is only for maintenance (replacement), while in the Free Cash Flow calculation, the cost of new Property, Plant, and Equipment due to business expansion is also deducted. There, Free Cash Flow is more conservative than Owner's Earnings.

In Don Yacktman's calculation of forward rate of return, he uses Free Cash Flow for the calculation. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation.

This is what Yacktman said in his March 2012 interview - when the S&P 500 was at 1400:

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over seven years. The reason we use seven years is because research shows that seven years is the length of the typical business cycle.

Therefore, as of Dec23, SANUWAVE Health's Forward Rate of Return (Yacktman) % is

Forward Rate of Return (Yacktman) % (Dec23)=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=0/0.013+0
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Free Cash Flow within a report period can be affected by management's decisions of capital spending. Therefore, it is important to look at long term when it comes to Free Cash Flow.


SANUWAVE Health Free Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's Free Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


SANUWAVE Health (SANUWAVE Health) Business Description

Traded in Other Exchanges
N/A
Address
11495 Valley View Road, Eden Prairie, MN, USA, 30024
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Executives
Andrew Walko officer: President 11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
James E Besser director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p. director, other: Director by Deputization MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank director 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price director 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh officer: President 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii 10 percent owner 200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski director 99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc. director 3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom officer: Interim CFO 11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli director, officer: Chief Executive Officer 510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins officer: Chief Financial Officer 11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino director PO BOX 376, LOBBY L., ANN ARBOR MI 48105